Publications

Antimicrobial activity and spectrum of daptomycin tested against Gram-positive strains collected in European hospitals: Results from 7 years of surveillance (2003-2009), Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Fusidic Acid Activity and Coverage of Gram-positive Pathogens Associated with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the USA (2008-2010), Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Activity of Ceftaroline Tested Against Common Pathogens Causing Complicated Skin and Soft Tissue Infections in European Medical Centres in 2009, Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Comprehensive analysis of telavancin activity against staphylococcal isolates from Europe (2009-2010), including strains with reduced susceptibility to vancomycin, Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Evaluation of L6 ribosomal protein alterations in fusidic acid-resistant Staphylococcus aureus: fitness cost and time-kill analysis, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Comparison of Tigecycline Activity Tested against Multidrug-resistant Bacteria Isolated from European Medical Centres in Two Time Periods: 2003-2005 and 2008-2010, Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Dalbavancin Surveillance Results for European Gram-positive Species (2006-2009) in a Contemporary Sample of 23,825 Strains, Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Dalbavancin Activity and Spectrum Evaluated Against a Contemporary (2007-2009) Worldwide Collection of Staphylococci (62,590 strains), Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Assessment of oritavancin activity tested against beta-haemolytic streptococci responsible for skin and skin structure infections in Europe (2008-2010), Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Analysis of Oritavancin Activity Tested against a Challenge Set of Staphylococcus aureus from Europe (2008-2010), Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Potency of radezolid (RX-1741) and torezolid (DA-7157) tested against a collection of linezolid-non-susceptible strains with genetically defined resistant mechantisms, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Activity of Solithromycin (CEM-101), a Novel Fluoroketolide Tested against Isolates Collected in Europe during 2010 Surveillance, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary (2010) European Pathogens Isolated from Patients with Community-Acquired Bacterial Pneumonia, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor. by Ross JE, Scangarella-Oman NE, Miller LA, Sader HS and Jones RN published in J. Clin. Microbiol. 2011; 49 (11): 3928-3930

Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone. by Ross JE, Liverman LC and Jones RN published in J. Clin. Microbiol. 2011; 49 (8): 3009-3011

Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: Activity against staphylococci and enterococci. by Putnam SD, Sader HS, Farrell DJ, Biedenbach DJ and Castanheira M published in Int. J. Antimicrob. Agents 2011; 37 (1): 39-45

In vitro activity of a novel broad-spectrum antifungal, E1210, and comparators against Aspergillus spp. as determined by CLSI and EUCAST broth microdilution methods. by Pfaller MA, Castanheira M, Messer SA and Jones RN published in Antimicrob. Agents Chemother. 2011; 55 (11): 5155-5158

Comparative activity of carbapenem testing: the COMPACT study. by Nordmann P, Picazo JJ, Mutters R, Korten V, Quintana A, Laeuffer JM, Seak JC, Flamm RK and Morrissey I published in J. Antimicrob. Chemother. 2011; 66 (5): 1070-1078

Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010). by Mendes RE, Sader HS, Farrell DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 71 (1): 93-97

In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) Gram-positive organisms collected in the United States. by Jones RN, Mendes RE, Sader HS and Castanheira M published in Clin. Infect. Dis. 2011; 52 (Suppl 7): S477-S486

Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: Results from an international surveillance study. by Jones RN, Farrell DJ, Mendes RE and Sader HS published in J. Antimicrob. Chemother. 2011; 66 (Suppl 3): iii69-iii80

Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model. by Hilliard JJ, Melton JL, Hall L, Abbanat D, Fernandez J, Ward CK, Bunting RA, Barron A, Lynch AS and Flamm RK published in Antimicrob. Agents Chemother. 2011; 55 (2): 836-844

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2006-2009) by Gales AC, Jones RN and Sader HS published in J. Antimicrob. Chemother. 2011; 66 (9): 2070-2074

Characterization of global patterns and the genetics of fusidic acid resistance. by Farrell DJ, Castanheira M and Chopra I published in Clin. Infect. Dis. 2011; 52 (Suppl 7): S487-S492

Genetic resistance elements carrying mef subclasses other than mef(A) in Streptococcus pyogenes. by Del Grosso M, Camilli R, Barbabella G, Blackman Northwood J, Farrell DJ and Pantosti A published in Antimicrob. Agents Chemother. 2011; 55 (7): 3226-3230

Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09. by Davies TA, Marie Queenan A, Morrow BJ, Shang W, Amsler K, He W, Lynch AS, Pillar C and Flamm RK published in J. Antimicrob. Chemother. 2011; 66 (10): 2298-2307

Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. by Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE and Melano RG published in Antimicrob. Agents Chemother. 2011; 55 (2): 703-712

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method. by Pfaller MA, Castanheira M, Diekema DJ, Messer SA and Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 71 (3): 252-259

Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States. by Mendes RE, Smith TC, Deshpande L, Diekema DL, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis.2011; 71 (2): 177-180

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method. by Pfaller MA, Hata K, Jones RN, Messer SA, Moet GJ and Castanheira M published in Diagn. Microbiol. Infect. Dis. 2011; 71 (2): 167-170

Definitions and epidemiology of Candida species not susceptible to echinocandins by Pfaller MA, Diekema DJ, Castanheira M and Jones RN published in Curr. Fungal Infect. Rep. 2011; 5: 120-127

Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility. by Healey KR, Katiyar SK, Castanheira M, Pfaller MA and Edlind TD published in Antimicrob. Agents Chemother. 2011; 55 (8): 3947-3949

Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). by Sader HS, Moet GJ, Farrell DJ and Jones RN published in Diagn. Microbiol. Infect. Dis 2011; 70 (3): 412-416

JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains. by Farrell DJ, Liverman LC, Biedenbach DJ, Jones RN published in Antimcrob. Agents Chemother. 2011; 55 (7): 3631-3634

Eight-year (2002-2009) summary of the linezolid (Zyvox Annual Appraisal of Potency and Spectrum; ZAAPS) program in European countries by Ross JE, Farrell DJ, Mendes RE, Sader HS, Jones RN published in J. Chem. 2011; 23 (2):71-76

Antimicrobial activty of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes. by Sader HS, Rhomberg PR, Farrell DJ, Jones RN published in Antimicrob. Agents Chemother. 2011; 55 (5): 2390-2394

OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded spectrum cephalosporins. by Poirel L, Castanheira M, Carrer A, Rodrguez CP, Jones RN, Smayevsky J and Nordmann P published in Antimicrob. Agents Chemother. 2011; 55 (6): 2546-2551

Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: An 11 year report from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Farrell DJ, Sader HS published in Int. J. Antimicrob. Agents 2011; 37 (6): 580-587

Molecular typing of antimicrobial-resistant Shiga-toxin-producing Escherichia coli strains (STEC) in Brazil. by Cergole-Novella MC, Pignatari ACC, Castanheira M and Guth BEC published in Res. Microbiol. 2011; 162 (2): 117-123

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: Report from the SENTRY Antimicrobial Surveillance Programme (2007-09). by Castanheira M, Mendes RE, Woosley LN and Jones RN published in J. Antimicrob. Chemother. 2011; 66 (6): 1409-1411

Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers. by Sader HS, Farrell DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 69 (2): 223-227

Susceptibility of Klebsiella spp. to colistin and polymyxin B: Results from the SENTRY Antimicrobial Surveillance Program (2006-2009). by Sader HS, Farrell DJ and Jones RN published in Int. J. Antimicrob. Agents. 2011; 37 (2): 174-175

Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). by Pfaller MA, Moet GJ, Messer SA, Jones RN and Castanheira M published in J. Clin. Microbiol. 2011; 49 (1): 396-399

Echinocandin and triazole antifungal susceptibility profiles for Candida spp. Cryptococcus neoformans, and Aspergillus fumigatus: Application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). by Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 69 (1): 45-50

Results of the Canadian Ward Surveillance Study (CANWARD) (2007-2009), a journal symposium. by Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 69 (3): 288

John A. Washington, MD (1936-2010). by Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 69 (3): 239

Investigation of the potential for mutational resistsance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study by Farrell DJ, Robbins M Rhys-Williams and Love WG published in Antimicrob. Agents Chemother. 2011; 55 (3): 1177-1181

In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci. by Farrell DJ, Krause KM and Benton BM published in Diagn. Microbiol. Infect. Dis. 2011; 69 (3): 257-279

In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler’s diarrhea and Clostridium difficile. by Farrrell DJ, Putnam SD Biedenbach DJ, Moro L, Bozzella R, Celasco G and Jones RN published in Antimicrob. Agents Chemother. 2011; 55 (3): 992-996

Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 by Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN and Mendes RE published in Antimicrob. Agents Chemother. 2011; 55 (3): 1274-1278